These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2865495)

  • 21. LAV/HTLV-III in 20-week fetus.
    Jovaisas E; Koch MA; Schäfer A; Stauber M; Löwenthal D
    Lancet; 1985 Nov; 2(8464):1129. PubMed ID: 2865600
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vitro diagnosis and anti-LAV/HTLV III].
    Meyer-Lüerssen D
    J Clin Chem Clin Biochem; 1985 Dec; 23(12):889-90. PubMed ID: 3007653
    [No Abstract]   [Full Text] [Related]  

  • 23. Leads from the MMWR. Recommendations for assisting in the prevention of perinatal transmission of HTLV-III/LAV and acquired immunodeficiency syndrome.
    JAMA; 1986 Jan; 255(1):25-7, 31. PubMed ID: 2999456
    [No Abstract]   [Full Text] [Related]  

  • 24. [Proof of diaplacental transmission of HTLV III/LAV before the 20th week of pregnancy].
    Schäfer A; Jovaisas E; Stauber M; Löwenthal D; Koch MA
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):88-9. PubMed ID: 3007265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa.
    Kreiss JK; Koech D; Plummer FA; Holmes KK; Lightfoote M; Piot P; Ronald AR; Ndinya-Achola JO; D'Costa LJ; Roberts P
    N Engl J Med; 1986 Feb; 314(7):414-8. PubMed ID: 3484804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HTLV-III and blood donors.
    Lancet; 1985 Apr; 1(8433):856. PubMed ID: 2858715
    [No Abstract]   [Full Text] [Related]  

  • 27. Leads from the MMWR. Summary: Recommendations for preventing transmission of infection with HTLV-III/LAV in the workplace.
    JAMA; 1985 Dec; 254(21):3023-6. PubMed ID: 2997494
    [No Abstract]   [Full Text] [Related]  

  • 28. [Human T-lymphotropic retrovirus and AIDS. HTLV-III is probably the cause of acquired immunodeficiency syndrome].
    Dobloug JH
    Tidsskr Nor Laegeforen; 1985 Jan; 105(1):50-2. PubMed ID: 2982219
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibodies to HTLV-III associated antigens in populations exposed to AIDS virus in France.
    Mathez D; Leibowitch J; Matheron S; Saimot AG; Catalan P; Zaguri D
    Lancet; 1984 Aug; 2(8400):460. PubMed ID: 6147522
    [No Abstract]   [Full Text] [Related]  

  • 30. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hospital hygiene. Notice of the Expert Federal Commission for AIDS on procedures to adopt in regard to patients with AIDS and to persons carrying anti-LAV/HTLV-III antibodies].
    Krankenpfl Soins Infirm; 1986 May; 79(5):74-5. PubMed ID: 3012197
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of anti-HTLV-III antibodies].
    Gerna G
    Riv Emoter Immunoematol; 1985; 32(2):195-7. PubMed ID: 3003878
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.
    Collier AC; Barnes RC; Handsfield HH
    Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast.
    Denis F; Barin F; Gershy-Damet G; Rey JL; Lhuillier M; Mounier M; Leonard G; Sangare A; Goudeau A; M'Boup S
    Lancet; 1987 Feb; 1(8530):408-11. PubMed ID: 2880215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.
    Nahmias AJ; Weiss J; Yao X; Lee F; Kodsi R; Schanfield M; Matthews T; Bolognesi D; Durack D; Motulsky A
    Lancet; 1986 May; 1(8492):1279-80. PubMed ID: 2872424
    [No Abstract]   [Full Text] [Related]  

  • 38. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody to HTLV-III in blood donors in central Africa.
    Van de Perre P; Munyambuga D; Zissis G; Butlzer JP; Nzaramba D; Clumeck N
    Lancet; 1985 Feb; 1(8424):336-7. PubMed ID: 2857383
    [No Abstract]   [Full Text] [Related]  

  • 40. HTLV and AIDS in West Germany.
    Born M; von der Helm K; Deinhardt F
    Lancet; 1984 Jan; 1(8370):222. PubMed ID: 6141359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.